Sacituzumab Tirumotecan Plus Immunotherapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Sacituzumab Tirumotecan Plus Immunotherapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma	Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence	Not yet recruiting	Phase 2	2026-07-07		NCT07686588

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Biying Chen	1

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials